NASDAQ: ARWRArrowhead Pharmaceuticals Inc Stock Ownership - Who owns Arrowhead Pharmaceuticals?
Insider buying vs selling
Have Arrowhead Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Michael S. Perry | Director | 2026-08-18 | 11,600 | $87.30 | $1.01MSell |
| Adeoye Y. Olukotun | Director | 2026-08-18 | 2,000 | $86.96 | $173.92kSell |
| Hongbo Lu | Director | 2026-05-12 | 2,970 | $76.88 | $228.33kSell |
| James C. Hamilton | Chief Medical Officer | 2026-04-23 | 10,000 | $75.00 | $750.00kSell |
| Daniel Joseph Apel | Chief Financial Officer | 2026-04-22 | 1,157 | $70.45 | $81.51kSell |
| Daniel Joseph Apel | Chief Financial Officer | 2026-04-22 | 3,208 | $70.11 | $224.91kSell |
| Daniel Joseph Apel | Chief Financial Officer | 2026-04-22 | 8,730 | $71.92 | $627.86kSell |
| James C. Hamilton | Chief Medical Officer | 2026-03-05 | 10,000 | $64.19 | $641.90kSell |
| Patrick 1. Obrien | COO | 2026-01-05 | 600 | $61.12 | $36.67kSell |
| James C. Hamilton | Chief Medical Officer | 2026-01-05 | 4,625 | $61.24 | $283.24kSell |
ARWR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ARWR insiders and whales buy or sell their stock.
ARWR Shareholders
What type of owners hold Arrowhead Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| David M. Knott | 3.97% | 5,609,690 | $352.01M | Insider |
| Christopher Richard Anzalone | 2.69% | 3,792,739 | $237.99M | Insider |
| Bruce D. Given | 0.60% | 850,730 | $53.38M | Insider |
| Patrick 1. Obrien | 0.39% | 547,408 | $34.35M | Insider |
| R. Bruce Stewart | 0.36% | 511,500 | $32.10M | Insider |
| Kenneth Allen Myszkowski | 0.32% | 455,433 | $28.58M | Insider |
| James C. Hamilton | 0.16% | 226,958 | $14.24M | Insider |
| Zhen Li | 0.14% | 201,700 | $12.66M | Insider |
| Martin Javier San | 0.14% | 198,497 | $12.46M | Insider |
| Daniel Joseph Apel | 0.12% | 162,905 | $10.22M | Insider |
ARWR vs Biotech Stocks
Arrowhead Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.